C12N 2710/16534
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral
C12N2710/16534 (Use of virus or viral component as vaccine) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 0
- Published applications
- 4
- Assignees
- 4
- Inventors
- 7
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
By publication year.
Recent patents
No granted patents in this class yet.
- Anti-angiogenic compositions and therapeutic applications thereof2 Oct 2014US 2014/0294941 A1Medestea Research & Production S.p.A.
- Preparation of Neutralizing Antibody to Human Herpesvirus 6 Glycoprotein Q1 and Analysis Thereof3 Apr 2014US 2014/0093526 A1National Institute of Biomedical Innovation
- Anti-angiogenic compositions and therapeutic applications thereof16 Jun 2011US 2011/0142918 A1The Phoebus Company, Inc.
- Human Herpesvirus 6A and 6B transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis25 Oct 2001US 2001/0033844 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.